Sequential phase I and II trials of stereotactic body radiotherapy for locally advanced hepatocellular carcinoma.
暂无分享,去创建一个
Zahra Kassam | James Brierley | Laura A. Dawson | Jenna Sykes | Jennifer J. Knox | M. Sherman | L. Dawson | Z. Kassam | John J. Kim | J. Brierley | R. Dinniwell | A. Bujold | C. Massey | C. Cho | R. Wong | J. Ringash | B. Cummings | J. Sykes | J. Knox | Morris Sherman | Bernard Cummings | Jolie Ringash | Alexis Bujold | Christine A. Massey | Charles Cho | Rebecca K. S. Wong | Rob E. Dinniwell
[1] Bernardino,et al. Prospective validation of the CLIP score: A new prognostic system for patients with cirrhosis and hepatocellular carcinoma , 2000, Hepatology.
[2] S. Perkins,et al. Phase I feasibility trial of stereotactic body radiation therapy for primary hepatocellular carcinoma , 2010, Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico.
[3] J. Sanabria,et al. Cyberknife Stereotactic Body Radiation Therapy for Nonresectable Tumors of the Liver: Preliminary Results , 2010, HPB surgery : a world journal of hepatic, pancreatic and biliary surgery.
[4] L. Dawson,et al. Radiation therapy for hepatocellular carcinoma , 2006, Cancer.
[5] Dong Han Lee,et al. Pilot Study of Stereotactic Body Radiotherapy for Huge Hepatocellular Carcinoma Unsuitable for Other Therapies , 2010, Tumori.
[6] T. Lacornerie,et al. Stereotactic Radiotherapy of Hepatocellular Carcinoma: Preliminary Results , 2010, Technology in cancer research & treatment.
[7] J. Bruix,et al. Prognosis of Hepatocellular Carcinoma: The BCLC Staging Classification , 1999, Seminars in liver disease.
[8] H. Jang,et al. Fractionated stereotactic radiotherapy in patients with primary hepatocellular carcinoma. , 2006, Japanese journal of clinical oncology.
[9] M. Mehta,et al. Angiogenic blockade and radiotherapy in hepatocellular carcinoma. , 2010, International journal of radiation oncology, biology, physics.
[10] J. Bruix,et al. Prospective Validation of the Cancer of the Liver Italian Program (CLIP) Score: A New Prognostic System for Patients With Cirrhosis and Hepatocellular Carcinoma , 2000, Hepatology.
[11] J. Wetterslev,et al. Transarterial (chemo)embolisation for unresectable hepatocellular carcinoma. , 2011, The Cochrane database of systematic reviews.
[12] Bellia Mario,et al. Prospective validation of the CLIP score, a new prognostic system for cirrhotic patients with hepatocellular carcinoma (RE: Hepatology 2000, 32/3: 679-80) , 2000 .
[13] Dong Han Lee,et al. Preliminary result of stereotactic body radiotherapy as a local salvage treatment for inoperable hepatocellular carcinoma , 2010, Journal of surgical oncology.
[14] H. Won,et al. Radiotherapy plus transarterial chemoembolization for hepatocellular carcinoma invading the portal vein: long-term patient outcomes. , 2012, International journal of radiation oncology, biology, physics.
[15] J. Bruix,et al. Management of hepatocellular carcinoma , 2005, Hepatology.
[16] Robert N. Anderson,et al. Annual Report to the Nation on the Status of Cancer, 1975–2007, Featuring Tumors of the Brain and Other Nervous System , 2011, Journal of the National Cancer Institute.
[17] G. Dusheiko,et al. Management of hepatocellular carcinoma. , 1992, Journal of hepatology.
[18] G. Abou-Alfa,et al. Doxorubicin plus sorafenib vs doxorubicin alone in patients with advanced hepatocellular carcinoma: a randomized trial. , 2010, JAMA.
[19] Hiroki Shirato,et al. Intercepting radiotherapy using a real-time tumor-tracking radiotherapy system for highly selected patients with hepatocellular carcinoma unresectable with other modalities. , 2007, International journal of radiation oncology, biology, physics.
[20] H. Jang,et al. Stereotactic body radiotherapy for patients with unresectable primary hepatocellular carcinoma: dose-volumetric parameters predicting the hepatic complication. , 2010, International journal of radiation oncology, biology, physics.
[21] Peter C Levendag,et al. Stereotactic body radiation therapy for primary and metastatic liver tumors: A single institution phase i-ii study , 2006, Acta oncologica.
[22] Junji Furuse,et al. The incidence and epidemiology of hepatocellular carcinoma: a global and regional perspective. , 2010, The oncologist.
[23] Tinsu Pan,et al. Four-dimensional computed tomography: image formation and clinical protocol. , 2005, Medical physics.
[24] Dong Han Lee,et al. Stereotactic body radiation therapy for inoperable hepatocellular carcinoma as a local salvage treatment after incomplete transarterial chemoembolization , 2012, Cancer.
[25] Y. Guan,et al. Transcatheter arterial chemoembolization in combination with radiotherapy for unresectable hepatocellular carcinoma: a systematic review and meta-analysis. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[26] Dieter Häussinger,et al. Sorafenib in advanced hepatocellular carcinoma. , 2008, The New England journal of medicine.
[27] Kristy K Brock,et al. Accuracy of daily image guidance for hypofractionated liver radiotherapy with active breathing control. , 2005, International journal of radiation oncology, biology, physics.
[28] H. Jang,et al. Long-term effect of stereotactic body radiation therapy for primary hepatocellular carcinoma ineligible for local ablation therapy or surgical resection. Stereotactic radiotherapy for liver cancer , 2010, BMC Cancer.
[29] Yoon-Koo Kang,et al. Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial. , 2009, The Lancet. Oncology.
[30] J. Seong,et al. Radiosensitizers in hepatocellular carcinoma. , 2011, Seminars in radiation oncology.
[31] Cynthia S. Johnson,et al. Stereotactic body radiotherapy for primary hepatocellular carcinoma. , 2011, International journal of radiation oncology, biology, physics.
[32] L. Dawson,et al. Individualized image guided iso-NTCP based liver cancer SBRT , 2006, Acta oncologica.
[33] O. Yokosuka,et al. Compensatory enlargement of the liver after treatment of hepatocellular carcinoma with carbon ion radiotherapy - relation to prognosis and liver function. , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[34] U. Haedinger,et al. Stereotactic radiotherapy of primary liver cancer and hepatic metastases , 2006, Acta oncologica.
[35] Sheng-Nan Lu,et al. The treatment responses in cases of radiation therapy to portal vein thrombosis in advanced hepatocellular carcinoma. , 2009, International journal of radiation oncology, biology, physics.
[36] L. Dawson,et al. Phase I Study of Sorafenib and SBRT for Advanced Hepatocellular Carcinoma , 2012 .
[37] Maria Hawkins,et al. Phase I study of individualized stereotactic body radiotherapy for hepatocellular carcinoma and intrahepatic cholangiocarcinoma. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[38] M. Feng,et al. Radiation therapy for hepatocellular carcinoma. , 2011, Seminars in radiation oncology.
[39] Joe Y. Chang,et al. Stereotactic ablative radiotherapy: what's in a name? , 2011, Practical radiation oncology.
[40] M. Okada,et al. [New response evaluation criteria in solid tumours-revised RECIST guideline (version 1.1)]. , 2009, Gan to kagaku ryoho. Cancer & chemotherapy.
[41] Robert Gray,et al. A Proportional Hazards Model for the Subdistribution of a Competing Risk , 1999 .
[42] C. Mathers,et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 , 2010, International journal of cancer.
[43] J. Bruix,et al. Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival , 2003, Hepatology.